|
HIV Vaccine Using Virus-Like Particles (VLPs)
Application
VLPs containing modified HIV Env have been developed for an AIDS vaccine, capable of inducing cellular and humoral immune responses; including neutralizing activities.
Key Benefits
VLPs are safer than live replicating vectored vaccines because of their lack of infectivity, allowing for use in immunocompromised patients.
HIV VLPs extract...
Published: 4/23/2024
Contributor(s): Richard Compans, Beatrice Hahn, Gale Smith
|